Stock Events

Stock Events

Halozyme Therapeutics (HALO) Q3 2013 Earnings

7AugConfirmed

Nov 12

Feb 13

May 13

Q3 2013

-0.2

-0.15

-0.09

-0.04

Details

Expected EPS

N/A

Actual EPS

-0.2

Surprise EPS

-0.2

Surprise Percent

+∞%

Description

Halozyme Therapeutics (HALO) has reported earnings of -0.2 per share for Q3 2013.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.